Home/Filings/4/0001562180-21-007902
4//SEC Filing

Hinton Bryan Richard 4

Accession 0001562180-21-007902

CIK 0001636422other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 5:19 PM ET

Size

8.9 KB

Accession

0001562180-21-007902

Insider Transaction Report

Form 4
Period: 2021-12-27
Hinton Bryan Richard
Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2021-12-27$39.56/sh260$10,2869,375 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-12-272602,340 total
    Exercise: $10.80Exp: 2028-09-27Common Stock (260 underlying)
  • Exercise/Conversion

    Common Stock

    2021-12-27$10.80/sh+260$2,8089,635 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
  • [F2]25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.

Issuer

Health Catalyst, Inc.

CIK 0001636422

Entity typeother

Related Parties

1
  • filerCIK 0001855244

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:19 PM ET
Size
8.9 KB